Challenges and Barriers to COVID-19 Vaccination: How to Prove Vaccine Effectiveness
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 7156
Special Issue Editor
Special Issue Information
Dear Colleagues,
As the Omicron variant spreads like wildfire across the globe, new challenges emerge for COVID-19 vaccination uptake. As this new variant appears not to spare vaccinated individuals, the effectiveness of current efforts to reach a high vaccine uptake are threatened. I would like to encourage the presentation to this Special Issue of recent advances in the understanding of the mechanisms affecting the vaccination decision, in light of the spread of new variants of concern. Adding new information on this subject may lead to a better understanding of how the unfolding of the current pandemic may jeopardize current immunization efforts and aid in the design of new communication strategies to sustain and promote vaccine uptake.
Kind regards
Dr. Marta Fadda
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- Sars-Cov-2
- vaccination
- effectiveness
- Omicron
- communication
- hesitancy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.